SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-094535
Filing Date
2021-03-25
Accepted
2021-03-25 16:44:20
Documents
5
Effectiveness Date
2021-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 d117615ds8.htm S-8 51095
2 EX-5.1 d117615dex51.htm EX-5.1 12322
3 EX-23.2 d117615dex232.htm EX-23.2 1760
4 GRAPHIC g117615dsp6.jpg GRAPHIC 2751
5 GRAPHIC g117615dsp8.jpg GRAPHIC 1835
  Complete submission text file 0001193125-21-094535.txt   72884
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254701 | Film No.: 21772945
SIC: 2836 Biological Products, (No Diagnostic Substances)